---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-083082"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2023-07-21T23:59:59+00:00"
generated_at: "2026-06-13T04:59:16.120096+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nasdaq grants Avenue Therapeutics extension to Nov 15, 2023 for stockholders' equity compliance

## Summary
- Nasdaq Staff granted extension until November 15, 2023 to regain compliance with minimum $2.5M stockholders' equity rule.
- Company originally notified of deficiency on May 19, 2023 for not meeting Nasdaq Listing Rule 5550(b)(1).
- Company intends to work diligently to regain compliance but cannot assure success.

## SEC filing metadata
- accession: 0001104659-23-083082
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2023-07-21T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465923083082/0001104659-23-083082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465923083082/tm2321816d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-083082
- JSON: https://secwatch.observer/filing/0001104659-23-083082.json
- Plain text: https://secwatch.observer/filing/0001104659-23-083082.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.